4
Changes in Ownership
Larimar Therapeutics, Inc. Filed Acc 0001062993-22-012308
Options or other derivatives
- Chief Financial Officer acquired 20,000 shares (grant or award)
From the SEC's structured data for this filing
Larimar Therapeutics, Inc. Filed Acc 0001062993-22-012308
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…